rosiglitazone has been researched along with Hyperandrogenism in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, MA; Al-Rifai, RH; Atkin, SL; Deshmukh, H; Östlundh, L; Sahebkar, A; Sathyapalan, T; Shah, N | 1 |
| Bhat, D; Butt, TP; Choh, N; Ganie, MA; Gupta, N; Masoodi, SR; Nisar, S; Rashid, A; Sofi, NY; Sood, M; Wani, IA | 1 |
| El-Kannishy, G; Shokeir, T | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Chan, JC; Chan, MH; Cheung, LP; Chow, FC; Haines, CJ; Lam, CW; Lam, PM; Ma, RC; Tam, WH; Tong, PC; Tsui, MH | 1 |
| Li, M; Lin, Y; Ma, Y; Zheng, Z | 1 |
| Shaarawy, M; Shobokshi, A | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Bahtiyar, G; Sacerdote, AS; Weiss, K | 1 |
1 review(s) available for rosiglitazone and Hyperandrogenism
| Article | Year |
|---|---|
Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Topics: Androgens; Dexamethasone; Female; Flutamide; Humans; Hyperandrogenism; Metformin; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Testosterone | 2023 |
6 trial(s) available for rosiglitazone and Hyperandrogenism
| Article | Year |
|---|---|
Coadministration of metformin or spironolactone enhances efficacy of rosiglitazone in management of PCOS.
Topics: Adolescent; Adult; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hyperandrogenism; India; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Spironolactone; Treatment Outcome; Young Adult | 2020 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome--a double-blind randomized placebo-controlled study.
Topics: Adult; Amenorrhea; Asian People; Chi-Square Distribution; Double-Blind Method; Female; Hong Kong; Humans; Hyperandrogenism; Hypoglycemic Agents; Menstrual Cycle; Placebo Effect; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult | 2011 |
[Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
Topics: Administration, Oral; Adult; Androstenedione; Blood Glucose; Body Weight; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Leptin; Lipids; Luteinizing Hormone; Menstruation; Neuropeptide Y; Ovulation; Polycystic Ovary Syndrome; Rosiglitazone; Testosterone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2002 |
Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.
Topics: Adult; Area Under Curve; Clomiphene; Drug Therapy, Combination; Estrogen Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Luteinizing Hormone; Menstruation; Polycystic Ovary Syndrome; Rosiglitazone; Thiazoles; Thiazolidinediones | 2003 |
Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Dehydroepiandrosterone Sulfate; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Rosiglitazone; Sex Hormone-Binding Globulin; Testosterone; Thiazolidinediones; Waist-Hip Ratio | 2006 |
2 other study(ies) available for rosiglitazone and Hyperandrogenism
| Article | Year |
|---|---|
Rosiglitazone as treatment for clomiphene citrate-resistant polycystic ovary syndrome: factors associated with clinical response.
Topics: Adult; Anovulation; Body Mass Index; Clomiphene; Drug Resistance; Egypt; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Infertility, Female; Luteinizing Hormone; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Regression Analysis; Retrospective Studies; Risk Factors; Rosiglitazone; Selective Estrogen Receptor Modulators; Testosterone; Thiazolidinediones; Ultrasonography; Young Adult | 2008 |
Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Adult; Aged; Antipsychotic Agents; Cortodoxone; Dehydroepiandrosterone; Endocrine Disruptors; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Luteinizing Hormone; Male; Metformin; Middle Aged; Radioimmunoassay; Rosiglitazone; Testosterone; Thiazolidinediones; Valproic Acid | 2007 |